Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02482753 |
Recruitment Status :
Completed
First Posted : June 26, 2015
Last Update Posted : January 12, 2022
|
Sponsor:
Chipscreen Biosciences, Ltd.
Information provided by (Responsible Party):
Chipscreen Biosciences, Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | March 2018 |
Actual Study Completion Date : | February 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):